Acinetobacter baumannii is regarded as a life-threatening pathogen associated with
community-acquired and nosocomial infections, mainly pneumonia. The rise in the number …

The Gram-negative opportunistic pathogen Acinetobacter baumannii has gain notoriety in
recent decades, primarily due to its propensity to cause nosocomial infections in critically ill …

Acinetobacter baumannii is a common cause of serious nosocomial infections. Although
community-acquired infections are observed, the vast majority occur in people with …

Acinetobacter baumannii is an emerging pathogen that poses a global health threat due to a
lack of therapeutic options for treating drug-resistant strains. In addition to acquiring …

Deciphering the virulence factors, regulation, and immune response to Acinetobacter
baumannii infection Acinetobacter baumannii is a gram-negative multidrug-resistant …

Acinetobacter infections have high rates of mortality due to an increasing incidence of
infections by multidrug-resistant (MDR) and extensively-drug-resistant (XDR) strains …

Acinetobacter baumannii has emerged as a major threat to global public health and is one
of the key human pathogens in healthcare (nosocomial and community-acquired) …

Acinetobacter baumannii is a Gram-negative pathogen responsible for a variety of
community-and hospital-acquired infections. It is recognized as a life-threatening pathogen …

Phenylacetic acid (PAA) is a central intermediate metabolite involved in bacterial
degradation of aromatic components. The bacterial PAA pathway mainly contains 12 …

Successful pathogens must be able to adapt to a multitude of stressors imposed by their
host. Acinetobacter baumannii has emerged as a major global health threat due to its …